This educational activity is free of charge.
Learning Objectives:
The goal of this activity is to better equip learners to evaluate and manage patients with vasodilatory shock through detailed discussions on the emerging treatment options.
Upon completion of this activity, learners will be able to:
- Describe vasodilatory shock from a pathophysiologic standpoint.
- Identify the relevant risk factors and clinical features associated with increased morbidity and mortality associated with vasodilatory shock.
- Explain the mechanism of action, pharmacologic properties, and safety and efficacy of current vasoactive agents, particularly angiotensin II, for the treatment of vasodilatory shock.
- Identify and critique the application of emerging therapies, including the use of angiotensin II, for the treatment of vasodilatory shock.
Commercial support:
This CME activity is supported by an educational grant from Viatris.
